| Fibrinolysis for patients with intermediate-risk pulmonary embolism G Meyer, E Vicaut, T Danays, G Agnelli, C Becattini, J Beyer-Westendorf, ... New England Journal of Medicine 370 (15), 1402-1411, 2014 | 1930 | 2014 |
| Oral rivaroxaban for the treatment of symptomatic pulmonary embolism HR Büller, MH Prins, AWA Lensing, H Decousus, BF Jacobson, E Minar, ... New England journal of medicine 366 (14), 1287-1297, 2012 | 1336 | 2012 |
| Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial P Mismetti, S Laporte, O Pellerin, PV Ennezat, F Couturaud, A Elias, ... Jama 313 (16), 1627-1635, 2015 | 557 | 2015 |
| Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism L Guérin, F Couturaud, F Parent, MP Revel, F Gillaizeau, B Planquette, ... Thrombosis and haemostasis 112 (09), 598-605, 2014 | 410 | 2014 |
| Impact of thrombolytic therapy on the long-term outcome of intermediate-risk pulmonary embolism SV Konstantinides, E Vicaut, T Danays, C Becattini, L Bertoletti, ... Journal of the American College of Cardiology 69 (12), 1536-1544, 2017 | 368 | 2017 |
| Pregnancy-adapted YEARS algorithm for diagnosis of suspected pulmonary embolism LM Van Der Pol, C Tromeur, IM Bistervels, F Ni Ainle, T Van Bemmel, ... New England Journal of Medicine 380 (12), 1139-1149, 2019 | 338 | 2019 |
| Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic … F Khan, A Rahman, M Carrier, C Kearon, JI Weitz, S Schulman, ... bmj 366, 2019 | 325 | 2019 |
| Prognostic factors for pulmonary embolism: the prep study, a prospective multicenter cohort study O Sanchez, L Trinquart, V Caille, F Couturaud, G Pacouret, N Meneveau, ... American journal of respiratory and critical care medicine 181 (2), 168-173, 2010 | 318 | 2010 |
| Effects of inspiratory muscle training in COPD patients: A systematic review and meta‐analysis M Beaumont, P Forget, F Couturaud, G Reychler The clinical respiratory journal 12 (7), 2178-2188, 2018 | 295 | 2018 |
| Six months vs extended oral anticoagulation after a first episode of pulmonary embolism: the PADIS-PE randomized clinical trial F Couturaud, O Sanchez, G Pernod, P Mismetti, P Jego, E Duhamel, ... Jama 314 (1), 31-40, 2015 | 287 | 2015 |
| Diagnosis and management of subsegmental pulmonary embolism G Le Gal, M Righini, F Parent, M Van Strijen, F Couturaud Journal of Thrombosis and Haemostasis 4 (4), 724-731, 2006 | 197 | 2006 |
| High prevalence of asymptomatic deep vein thrombosis on admission in a medical unit among elderly patients E Oger, L Bressollette, M Nonent, K Lacut, B Guias, F Couturaud, ... Thrombosis and haemostasis 88 (10), 592-597, 2002 | 163 | 2002 |
| Tinzaparin and enoxaparin given at prophylactic dose for eight days in medical elderly patients with impaired renal function I Mahé, M Aghassarian, L Drouet, K Lacut, JJ Heilmann, D Mottier, ... Thrombosis and haemostasis 97 (04), 581-586, 2007 | 149 | 2007 |
| Current incidence of venous thromboembolism and comparison with 1998: a community-based study in Western France A Delluc, C Tromeur, F Le Ven, M Gouillou, N Paleiron, L Bressollette, ... Thrombosis and haemostasis 116 (11), 967-974, 2016 | 143 | 2016 |
| Rivaroxaban vs dalteparin in cancer-associated thromboembolism: a randomized trial B Planquette, L Bertoletti, A Charles-Nelson, S Laporte, C Grange, I Mahé, ... Chest 161 (3), 781-790, 2022 | 140 | 2022 |
| Interaction between hyperhomocysteinemia, mutated methylenetetrahydrofolatereductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis MBAJ Keijzer, M den Heijer, HJ Blom, GMJ Bos, HPJ Willems, ... Thrombosis and haemostasis 88 (11), 723-728, 2002 | 135 | 2002 |
| Long-term risk for major bleeding during extended oral anticoagulant therapy for first unprovoked venous thromboembolism: a systematic review and meta-analysis F Khan, T Tritschler, M Kimpton, PS Wells, C Kearon, JI Weitz, HR Büller, ... Annals of internal medicine 174 (10), 1420-1429, 2021 | 129 | 2021 |
| Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial J Halton, LR Brandão, M Luciani, L Bomgaars, E Chalmers, LG Mitchell, ... The Lancet Haematology 8 (1), e22-e33, 2021 | 129 | 2021 |
| Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial PM Roy, A Penaloza, O Hugli, FA Klok, A Arnoux, A Elias, F Couturaud, ... European heart journal 42 (33), 3146-3157, 2021 | 124 | 2021 |
| Decrease in sensitivity of D-dimer for acute venous thromboembolism after starting anticoagulant therapy F Couturaud, C Kearon, SM Bates, JS Ginsberg Blood coagulation & fibrinolysis 13 (3), 241-246, 2002 | 119 | 2002 |
